This course will cover all aspects of Clinical and Laboratory Haemostasis and Thrombosis.
Maintenance of blood fluidity and patency of the vascular system is crucial for normal human physiology. The term ‘haemostasis’ refers to the normal response of the vessel to injury by forming a clot that serves to limit haemorrhage. Thrombosis is pathological clot formation that results when haemostasis is excessively activated in the absence of bleeding. Under normal physiological conditions there is a delicate equilibrium between the pathological states of hypercoagulability and hypocoagulability in the circulating blood. Both inherited and acquired disorders can result in either bleeding or thrombosis.
Thrombosis may occur in veins (venous thrombosis) or in arteries (arterial thrombosis). Venous thrombosis leads to congestion of the affected part of the body, while arterial thrombosis affects the blood supply and leads to damage of the tissue supplied by that artery (ischaemia and necrosis). Fragments of either an arterial or a venous thrombus can also break off as an embolus which can travel through the circulation and cause thromboembolism. Accurate clinical and laboratory diagnosis of these disorders is therefore not only critical for the prevention of significant morbidity and mortality but improves patient care and quality of life through prevention and treatment of future bleeding and thrombotic events.
Our understanding of these physiological and pathophysiological conditions has also improved significantly over recent years. This has not only resulted in improved diagnosis but in the evolution of state of the art modern laboratory testing and therapies for both bleeding and thrombotic disorders. As the subject is also rapidly and continually evolving, this course aims to continually give up to date training from established clinicians and scientists in the field.
- Up-to-date physiology and pathophysiology of Haemostasis and Thrombosis
- Comprehensive training in basic and advanced clinical and laboratory practice in Haemostasis and Thrombosis
- Interactive state of the art Lectures from established clinicians and scientists in the field
- FRCPath focussed
- 2 live sessions on Case based data interpretation
- 1 live session on COVID-19 and Haemostasis
- 1 live Q&A session
Programme team:
- Alex Brill, University of Birmingham
- Tina Dutt, Royal Liverpool Hospital
- Keith Gomez, The Royal Free Hospital
- David Gurney, University Hospitals Birmingham
- Claire Harrison, Guy's and St Thomas'
- Paul Harrison, University of Birmingham
- Beverley Hunt, Guy's and St Thomas'
- Ian Jennings, Sheffield
- Steve Kitchen, Sheffield Teaching Hospitals
- Will Lester, University Hospitals Birmingham
- Gill Lowe, University Hospitals Birmingham
- Peter MacCallum, Royal London
- Gary Moore, Technoclone
- Neil Morgan, University of Birmingham
- Jayashree Motwani, Birmingham Women's and Children's Hospital
- Sue Pavord, University of Oxford
- Charles Percy, University Hospitals Birmingham
- Susie Shapiro, Oxford University Hospitals
- Mark Thomas, University of Birmingham
- Henry Watson, NHS Grampian
- Steve Watson, University of Birmingham
Dates of the course:
1st of February - 30th of April 2025
The live online zoom week dates are TBC.
Course content:
(Provisional)
Session 1
| Talk | Session Title |
|---|
| 1 |
Course Overview and Welcome
Dr. Paul Harrison, University of Birmingham |
| 2 |
Overview of Haemostasis
Dr. Paul Harrison, University of Birmingham |
| 3 |
Laboratory Investigation of Coagulation Disorders
Dr. David Gurney, University Hospital Birmingham |
| 4 |
Platelet Biochemistry & Function,
Professor Steve Watson, University of Birmingham |
| 5 |
Paediatric Haemostasis & Rare Inherited Defects
Dr. Jayashree Motwani, Birmingham Children's Hospital |
| 6 |
Modern Management of Haemophilia,
Dr Keith Gomez, Royal Free London NHSFT |
Session 2
| Talk | Session Title |
|---|
| 7 |
Anti-Platelet Drugs
Dr. Mark Thomas, University of Birmingham |
| 8 |
Laboratory Control of Anticoagulants
Dr Steve Kitchen, Royal Hallamshire Hospital, Sheffield |
| 9 |
Antiphospholipid Syndrome & Management,
Professor Beverley Hunt, Guy's and St Thomas' NHSFT |
| 10 |
Neutrophil Extracellular Traps – a new paradigm in T&H
Dr Alex Brill, University of Birmingham |
| 11 |
Thrombophilia & Duration of Anticoagulation
Dr Will Lester, University Hospital Birmingham |
| 12 |
Acquired Risk Factors for Thrombosis I (Obesity, Malignancy, PNH, nephrotic syndrome)
TBC |
Session 3
| Talk | Session Title |
|---|
| 13 |
Laboratory Diagnosis and Treatment of VWD
Dr Will Lester, University Hospital Birmingham |
| 14 |
QC and EQA in Blood Coagulation
Dr Ian Jennings, Sheffield |
| 15 |
Acquired Risk Factors for Thrombosis II (VTE Prophylaxis, HIT)
Dr Peter MacCallum, Royal Free London NHSFT |
| 16 |
Myeloproliferative Diseases – Investigation/Management
Professor Claire Harrison, Guy's and St Thomas' NHSFT |
| 17 |
Major Trauma and Haemostasis
Dr Paul Harrison, University of Birmingham |
Session 4
| Talk | Session Title |
|---|
| 18 |
Anticoagulants: New and Old
Dr Henry Watson, Aberdeen Royal Infirmary |
| 19 |
Management of Acquired Bleeding Disorders
Dr Charles Percy, University Hospital Birmingham |
| 20 |
Laboratory Data Interpretation
Dr David Gurney, University Hospital Birmingham |
| 21 |
Thrombotic Microangiopathies - Laboratory Investigations & Treatment
Dr Tina Dutt, Royal Liverpool Hospital |
| 22 |
Advances in genetic testing in Haemostasis
Dr Neil Morgan, University of Birmingham |
Session 5
| Talk | Session Title |
|---|
| 23 |
Antiphospholipid antibody assays
Dr Gary Moore, Technoclone |
| 24 |
Lupus anticoagulant testing
Dr Gary Moore, Technoclone |
| 25 |
ITP
Dr Sue Pavord, Oxford |
| 26 |
Point of Care Testing & Treatment
Dr Dianne Kitchen, Sheffield |
| 27 |
Thrombotic Disorders in Pregnancy
Dr Catherine Bagot, Glasgow |
Programme subject to change.
How to apply:
To register for the course, please visit our online shop.
To enquire about the course, please use our enquiry form.
See how the University of Birmingham uses your data, view the Event attendee privacy notice.